Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study

The aim of the study was to evaluate the safety and efficacy of a new chemo-radiotherapy regimen for patients with locally advanced pancreatic cancer (LAPC). Patients were treated as follows: gemcitabine 1000 mg/m(2) on day 1, and oxaliplatin 100 mg/m(2) on day 2, every two weeks (GEMOX regimen) for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Passardi, Alessandro, Scarpi, Emanuela, Neri, Elisa, Parisi, Elisabetta, Ghigi, Giulia, Ercolani, Giorgio, Gardini, Andrea, La Barba, Giuliano, Pagan, Flavia, Casadei-Gardini, Andrea, Valgiusti, Martina, Ferroni, Fabio, Frassineti, Giovanni Luca, Romeo, Antonino
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562444/
https://ncbi.nlm.nih.gov/pubmed/31086093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050663
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados